Novartis Agrees to Acquire Excellergy, Inc. to Strengthen Allergy Leadership with Next-Generation Anti-IgE Innovation Novartis has announced a strategic agreement to acquire Excellergy, a privately held biotechnology company focused on the development of next-generation therapies targeting immunoglobulin E (IgE)-driven diseases.…
Nordic Cold Chain Solutions Unveils Innovation Lab Focused on GLP-1 and Small-Format Packaging Solutions Nordic Cold Chain Solutions has announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab, a new customer-focused initiative aimed at addressing the growing logistical…
Bio-Techne Expands Spatial Biology Capabilities with Modular Enhancement of the COMET™ Suite Bio-Techne Corporation has announced a significant expansion of its spatial biology capabilities with the introduction of new tools within its COMET™ technology platform. The launch of SPYRE™ Focus…
Novo Nordisk A/S Reports Up to 2.16% HbA1c Reduction with Triple Agonist UBT251 After 24 Weeks in Phase 2 Trial Among Chinese Patients with Type 2 Diabetes The United Laboratories International Holdings Limited and Novo Nordisk A/S have announced encouraging…
Seaport Therapeutics, Founded by PureTech, Reports Science Translational Medicine Publication Highlighting GlyphAllo™ (SPT-300) as a First-in-Class Triglyceride-Mimetic Prodrug Achieving Therapeutic Drug Levels in Humans PureTech Health plc has highlighted a significant scientific milestone achieved by its Founded Entity, Seaport Therapeutics,…
NBDF’s Pathway to Cures Launches Spark Biomedical’s LUNA Trial to Explore Non-Drug Treatment for Heavy Menstrual Bleeding For many women and adolescent girls living with inherited bleeding disorders, heavy menstrual bleeding (HMB) remains one of the most physically and emotionally…
Enhancing Digital Health Capabilities Through Integrated Blended Learning Approaches Across many low- and middle-income countries, the promise of digital health transformation is often constrained by a persistent and complex reality: fragmented systems, overlapping digital tools, and increasing pressure on health…
Roche Launches State-of-the-Art Institute of Human Biology Facility to Advance Next-Generation Human Model Systems in Drug Discovery and Development Roche has officially inaugurated a new state-of-the-art research facility to serve as the home of its Institute of Human Biology (IHB),…
Biogen to Showcase Late-Breaking Phase 2 AMETHYST Data on Litifilimab in Cutaneous Lupus Erythematosus at the 2026 American Academy of Dermatology Annual Meeting Biogen Inc. has announced a series of upcoming scientific presentations at the prestigious American Academy of Dermatology…
Allergan Aesthetics Highlights Shifting Trends in Modern Aesthetic Care Through Global Survey and Enhanced Educational Initiatives Allergan Aesthetics, a division of AbbVie and a globally recognized leader in the field of medical aesthetics, has unveiled a comprehensive new body of…
Finerenone Achieves Primary Endpoint in Pivotal Phase III FIND-CKD Trial for Non-Diabetic Chronic Kidney Disease Patients The Phase III study FIND-CKD, evaluating the efficacy and safety of finerenone (Kerendia™) versus placebo when added to standard of care in adult patients…
Celltrion Poised to Gain from Global Biosimilar Regulatory Harmonization, Enhancing Economies of Scale from Development to Manufacturing and Direct Commercialization Celltrion announced today that it will immediately incorporate newly announced global regulatory updates aimed at streamlining biosimilar development into its…